Champions Oncology, Inc.

Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the imp…

Biotechnology

US, Hackensack [HQ]

Analysts
Dividend Payments
Government Awards
Insiders
Lobbying Expenses
Segment Revenues
Shareholder Structure
Supply / Portfolio
Valuation Models [Soon]

Major Shareholders · Proxy Ben. Owners

Shareholders

Major Shareholders · Structure

Breakdown

The breakdown presents the total weighting of the relevant parties: Institutes, Insiders & Public. for Champions Oncology, Inc.

Champions Oncology, Inc. can't present any analysts estimates at the moment detail analysis.

Intraday

Shares Outstanding

13,819,200

Volume

24,808

Volume on Avg.

43,640

Beneficial Owners Beta

Beneficial owners who control a significant portion of the shares outstanding.

SEC Source

Form 3/4/5

Owner	Shares	Equivalence - $9.00 per share	Last Form/Filing	Last Transaction
10% Holder
Tobin Scott R Internal : Director	View the form. Palmy doesn't track derivative holdings.
Officers/Directors Below 10%
Breitfeld Philip P. Internal : Director	0	$0	11/07/23	0 x $0 = $0
Sidransky David Internal : Director	0	$0	11/09/21	0 x $0 = $0
Mendelson Daniel Newman Internal : Director	183,681	$1,653,129.00	01/04/24	P 500 x $5.83 = $2,915.00
Tobin Scott R Internal : Director	30,000	$270,000.00	10/13/22	M 10,000 x $3.21 = $32,100.00
Ackerman Joel Internal : Director	0	$0	11/18/24	0 x $0 = $0
Davis Brady Internal : President	0	$0	04/01/24	0 x $0 = $0
Morris Ronnie Internal : CEO	858,878	$7,729,902.00	03/21/23	P 12,382 x $4.04 = $50,023.28